Innovation on Display Featuring Three JLABS @ Washington, DC Resident Companies

Published on :

Several Johnson & Johnson Innovation – JLABS (JLABS) @ Washington, DC resident companies had the opportunity to meet and greet and make presentations at the 2023 BLUE KNIGHT™ Symposium and BIO International Convention during the beginning of June. The Blue Knight Symposium is part of Blue Knight, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), within the U.S. Department of Health and Human Services. Hosted in association with the 2023 BIO International Convention, the Symposium was held in Boston from June 5-8, 2023.

Announcing the BLUE KNIGHT™ Resident QuickFire Challenge: Accelerating Project NextGen

Published on :

Announcing the BLUE KNIGHT™ Resident QuickFire Challenge: Accelerating Project NextGen June 4, 2023 – Johnson & Johnson Innovation, together with The Biomedical Advanced Research and Development Authority (BARDA), is proud to announce [….]

Johnson & Johnson Innovation Opens Applications for Three Funding Opportunities to Fuel Your Life Science Business

Published on :

Johnson & Johnson Innovation Opens Applications for Three Funding Opportunities to Fuel Your Life Science Business By Sarah EllinwoodJune 5, 2023 It’s no secret that the current state of the [….]

TEDCO and JLABS Discuss Innovation and Workforce Diversity in Maryland

Published on :

TEDCO recently launched ‘TEDCO Talks’, a series featuring thought leaders in economic development across the State of Maryland. On May 28th, TEDCO CEO & Executive Director, Troy LeMaile-Stovall interviewed Sally Allain, Head of JLABS @ Washington DC, about the future of the innovation ecosystem and the crucial role that JLABS will play in advancing the BioHealth Capital Region.

2021 Mid-Atlantic Science and Technology Virtual Showcase

Published on :

The ISPE Chesapeake Bay Area Chapter Mid-Atlantic Science & Technology (MAST) Virtual Showcase, hosted on May 19th, 2021, provided a platform for life science companies to discuss strategies for addressing challenges in the life science industry.

5 Questions with Rachel Rath, MBA, MPH, Director, BARDA Alliance for Johnson & Johnson Innovation, JLABS @ Washington, DC

Published on :

Rachel is the Director of the BARDA Alliance for Johnson & Johnson Innovation, based at JLABS @ Washington, DC. In this role, she is responsible for managing the BLUE KNIGHT™ collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA). BLUE KNIGHT™ focuses on addressing public-health threats and emerging infectious diseases by supporting companies with emerging science and technology solutions that aim to improve health security and responses.